The New Normal: How the Supply Chain has Been Impacted by COVID-19
Summary: The pandemic has touched almost every aspect of our lives, and the pharmaceutical industry had to adapt quickly if it was to continue to supply important medicines, while also racing to develop vaccines and treatments. Supply chains have come under intense pressure, and companies of all kinds have had to adapt to this “new normal” to avoid delays. As a global development and manufacturing partner that supplies medicines, clinical trial materials and health products to millions of patients and consumers, Catalent needed to balance the continued work on thousands of products while also supporting the scale up of COVID-19 vaccines and therapies for over 60 customers from small/virtual biotechs to mid- and large pharma. During this Q&A, Catalent discusses the challenges they faced and solutions they implemented to overcome this daunting challenge.